BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35941163)

  • 21. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum miRNA expression profiles change in autoimmune vitiligo in mice.
    Shi YL; Weiland M; Lim HW; Mi QS; Zhou L
    Exp Dermatol; 2014 Feb; 23(2):140-2. PubMed ID: 24401108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs as potential biomarkers for coronary plaque rupture.
    Li S; Lee C; Song J; Lu C; Liu J; Cui Y; Liang H; Cao C; Zhang F; Chen H
    Oncotarget; 2017 Jul; 8(29):48145-48156. PubMed ID: 28624816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs as biomarkers of adult Crohn's disease.
    Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects.
    Gu H; Chen L; Xue J; Huang T; Wei X; Liu D; Ma W; Cao S; Yuan Z
    Biomed Pharmacother; 2019 Jan; 109():823-830. PubMed ID: 30551536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes.
    Aguennouz M; Guarneri F; Oteri R; Polito F; Giuffrida R; Cannavò SP
    J Dermatol Sci; 2021 Jan; 101(1):22-29. PubMed ID: 33176966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
    BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes.
    Šahmatova L; Tankov S; Prans E; Aab A; Hermann H; Reemann P; Pihlap M; Karelson M; Abram K; Kisand K; Kingo K; Rebane A
    Acta Derm Venereol; 2016 Aug; 96(6):742-7. PubMed ID: 26941046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
    Wu J; Fan CL; Ma LJ; Liu T; Wang C; Song JX; Lv QS; Pan H; Zhang CN; Wang JJ
    Thromb Haemost; 2017 May; 117(5):992-1001. PubMed ID: 28251236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.